Literature DB >> 34011373

Multicopy targets for Plasmodium vivax and Plasmodium falciparum detection by colorimetric LAMP.

Oscar Nolasco1,2, Jhoel Montoya3, Ana L Rosales Rosas4, Scarlett Barrientos4, Anna Rosanas-Urgell5, Dionicia Gamboa6,4,7.   

Abstract

BACKGROUND: Loop-mediated isothermal amplification (LAMP) for malaria diagnosis at the point of care (POC) depends on the detection capacity of synthesized nucleic acids and the specificity of the amplification target. To improve malaria diagnosis, new colorimetric LAMP tests were developed using multicopy targets for Plasmodium vivax and Plasmodium falciparum detection.
METHODS: The cytochrome oxidase I (COX1) mitochondrial gene and the non-coding sequence Pvr47 for P. vivax, and the sub-telomeric sequence of erythrocyte membrane protein 1 (EMP1) and the non-coding sequence Pfr364 for P. falciparum were targeted to design new LAMP primers. The limit of detection (LOD) of each colorimetric LAMP was established and assessed with DNA extracted by mini spin column kit and the Boil & Spin method from 28 microscopy infections, 101 malaria submicroscopic infections detected by real-time PCR only, and 183 negatives infections by both microscopy and PCR.
RESULTS: The LODs for the colorimetric LAMPs were estimated between 2.4 to 3.7 parasites/µL of whole blood. For P. vivax detection, the colorimetric LAMP using the COX1 target showed a better performance than the Pvr47 target, whereas the Pfr364 target was the most specific for P. falciparum detection. All microscopic infections of P. vivax were detected by PvCOX1-LAMP using the mini spin column kit DNA extraction method and 81% (17/21) were detected using Boil & Spin sample preparation. Moreover, all microscopic infections of P. falciparum were detected by Pfr364-LAMP using both sample preparation methods. In total, PvCOX1-LAMP and Pfr364-LAMP detected 80.2% (81 samples) of the submicroscopic infections using the DNA extraction method by mini spin column kit, while 36.6% (37 samples) were detected using the Boil & Spin sample preparation method.
CONCLUSION: The colorimetric LAMPs with multicopy targets using the COX1 target for P. vivax and the Pfr364 for P. falciparum have a high potential to improve POC malaria diagnosis detecting a greater number of submicroscopic Plasmodium infections.

Entities:  

Keywords:  Colorimetric LAMP; Cox1; Malaria; Molecular diagnosis; PfEMP1; Pfr364; Pvr47

Year:  2021        PMID: 34011373     DOI: 10.1186/s12936-021-03753-8

Source DB:  PubMed          Journal:  Malar J        ISSN: 1475-2875            Impact factor:   2.979


  38 in total

Review 1.  Diagnosis of malaria: a review of alternatives to conventional microscopy.

Authors:  T Hänscheid
Journal:  Clin Lab Haematol       Date:  1999-08

2.  Reliability of malaria microscopy in epidemiological studies: results of quality control.

Authors:  A H Kilian; W G Metzger; E J Mutschelknauss; G Kabagambe; P Langi; R Korte; F von Sonnenburg
Journal:  Trop Med Int Health       Date:  2000-01       Impact factor: 2.622

Review 3.  An Update on Malaria Rapid Diagnostic Tests.

Authors:  Avinash N Mukkala; Jason Kwan; Rachel Lau; David Harris; Dylan Kain; Andrea K Boggild
Journal:  Curr Infect Dis Rep       Date:  2018-10-23       Impact factor: 3.725

4.  A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests.

Authors:  Dionicia Gamboa; Mei-Fong Ho; Jorge Bendezu; Katherine Torres; Peter L Chiodini; John W Barnwell; Sandra Incardona; Mark Perkins; David Bell; James McCarthy; Qin Cheng
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

Review 5.  Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis.

Authors:  Lucy C Okell; Azra C Ghani; Emily Lyons; Chris J Drakeley
Journal:  J Infect Dis       Date:  2009-11-15       Impact factor: 5.226

6.  Hotspots of Malaria Transmission in the Peruvian Amazon: Rapid Assessment through a Parasitological and Serological Survey.

Authors:  Angel Rosas-Aguirre; Niko Speybroeck; Alejandro Llanos-Cuentas; Anna Rosanas-Urgell; Gabriel Carrasco-Escobar; Hugo Rodriguez; Dionicia Gamboa; Juan Contreras-Mancilla; Freddy Alava; Irene S Soares; Edmond Remarque; Umberto D Alessandro; Annette Erhart
Journal:  PLoS One       Date:  2015-09-10       Impact factor: 3.240

7.  Micro-heterogeneity of malaria transmission in the Peruvian Amazon: a baseline assessment underlying a population-based cohort study.

Authors:  Angel Rosas-Aguirre; Mitchel Guzman-Guzman; Dionicia Gamboa; Raul Chuquiyauri; Roberson Ramirez; Paulo Manrique; Gabriel Carrasco-Escobar; Carmen Puemape; Alejandro Llanos-Cuentas; Joseph M Vinetz
Journal:  Malar J       Date:  2017-08-04       Impact factor: 2.979

8.  Rapid diagnostic tests for malaria diagnosis in the Peruvian Amazon: impact of pfhrp2 gene deletions and cross-reactions.

Authors:  Jessica Maltha; Dionicia Gamboa; Jorge Bendezu; Luis Sanchez; Lieselotte Cnops; Philippe Gillet; Jan Jacobs
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

9.  pLDH level of clinically isolated Plasmodium vivax and detection limit of pLDH based malaria rapid diagnostic test.

Authors:  Jin Woo Jang; Chi Hyun Cho; Eun Taek Han; Seong Soo A An; Chae Seung Lim
Journal:  Malar J       Date:  2013-06-03       Impact factor: 2.979

10.  Predominance of asymptomatic and sub-microscopic infections characterizes the Plasmodium gametocyte reservoir in the Peruvian Amazon.

Authors:  Eduard Rovira-Vallbona; Juan José Contreras-Mancilla; Roberson Ramirez; Mitchel Guzmán-Guzmán; Gabriel Carrasco-Escobar; Alejandro Llanos-Cuentas; Joseph M Vinetz; Dionicia Gamboa; Anna Rosanas-Urgell
Journal:  PLoS Negl Trop Dis       Date:  2017-07-03
View more
  1 in total

1.  Usefulness of Malachite-Green LAMP for Diagnosis of Plasmodium and Five Human Malaria Species in a Nonendemic Setting.

Authors:  Alexandra Martín Ramírez; Marta Lanza Suárez; Carlota Muñoz García; Shamilah R Hisam; Ana Perez-Ayala; José M Rubio
Journal:  Am J Trop Med Hyg       Date:  2022-03-14       Impact factor: 3.707

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.